Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today
Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today

We deliver Mobile Wallet Market Research and SWOT Analysis from Alternative Energy to Pharmaceuticals and Healthcare Market Research Reports to Digital Media.

Skip to Main Content »

Search Site
Researchers Currently Online:1741

Traumatic Brain Injury (TBI) Therapeutics - Pipeline Assessment and Market Forecasts to 2017


Traumatic Brain Injury (TBI) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Double click on above image to view full picture

Zoom Out
Zoom In
Additional Information
Price $2,000.00
Meta Description No
Publisher GlobalData
Date of Report Dec 4, 2011
Quick Overview
Traumatic Brain Injury (TBI) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Summary

GlobalData, the industry analysis specialist, has released its new report, “Traumatic Brain Injury (TBI) Therapeutics - Pipeline Assessment and Market Forecasts to 2017”. The report is an essential source of information and analysis on the global Traumatic Brain Injury Therapeutics market. The report identifies the key trends shaping and driving the global Traumatic Brain Injury Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Traumatic Brain Injury Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

The report provides information on the key drivers and challenges of the Traumatic Brain Injury Therapeutics market. Its scope includes -
- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Traumatic Brain Injury Therapeutics market revenues data from 2005 to 2009, forecast for eight years to 2017.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
- Analysis of the current and future competition in the seven key countries Traumatic Brain Injury Therapeutics market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Traumatic Brain Injury Therapeutics therapeutics market.
- Analysis of key recent licensing and partnership agreements in Traumatic Brain Injury Therapeutics market

Reasons to buy

The report will enhance your decision making capability. It will allow you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global Traumatic Brain Injury Therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Traumatic Brain Injury Therapeutics market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- What’s the next big thing in the global Traumatic Brain Injury Therapeutics market landscape? – Identify, understand and capitalize.
Table of Contents
1 Table of contents
1 Table of contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 TBI Therapeutics: Introduction 6
2.1 Disease Overview 6
2.2 Epidemiology 9
2.3 Etiology 9
2.4 Signs and Symptoms 10
2.5 Diagnosis 10
2.6 Treatment and management Pattern 12
2.7 GlobalData Pipeline Report Guidance 14
3 TBI Therapeutics: Market Characterization 15
3.1 Overview 15
3.2 TBI Therapeutics Market Size (2005–2010) – Global 15
3.3 TBI Therapeutics Market Forecast (2010–2017) – Global 16
3.4 TBI Therapeutics Market Size (2005–2010) – The US 17
3.5 TBI Therapeutics Market Forecast (2010–2017) – The US 18
3.6 TBI Therapeutics Market Size (2005–2010) – France 19
3.7 TBI Therapeutics Market Forecast (2010–2017) – France 20
3.8 TBI Therapeutics Market Size (2005–2010) – Germany 21
3.9 TBI Therapeutics Market Forecast (2010-2017) – Germany 22
3.10 TBI Therapeutics Market Size (2005–2010) – Italy 23
3.11 TBI Therapeutics Market Forecast (2010–2017) – Italy 24
3.12 TBI Therapeutics Market Size (2005–2010) – Spain 25
3.13 TBI Therapeutics Market Forecast (2010–2017) – Spain 26
3.14 TBI Therapeutics Market Size (2005–2010) – The UK 27
3.15 TBI Therapeutics Market Forecast (2010–2017) – The UK 28
3.16 TBI Therapeutics Market Size (2005–2010) – Japan 29
3.17 TBI Therapeutics Market Forecast (2010–2017) – Japan 30
3.18 Drivers and Barriers for TBI Therapeutics Market 31
3.18.1 Drivers for the TBI Therapeutics Market 31
3.18.2 Barriers for the TBI Therapeutics Market 31
3.19 Opportunity and Unmet Need Analysis 32
3.19.1 Opportunity and Unmet Need in the TBI Market, 2010 32
3.20 Key Takeaway 32
4 TBI Therapeutics: Competitive Assessment 33
4.1 Overview 33
4.2 Strategic Competitor Assessment 33
4.3 Product Profile for the Major Marketed Products in the TBI Therapeutics 34
4.3.1 NovoSeven 34
4.3.2 Mannitol 35
4.4 Key Takeaway 35
5 TBI Therapeutics: Pipeline Assessment 36
5.1 Overview 36
5.2 Strategic Pipeline Assessment 36
5.3 TBI Therapeutics Pipeline – Pipeline by Phases of Development 36
5.3.1 TBI Therapeutics – Phase III Pipeline 37
5.3.2 TBI Therapeutics –Phase II Pipeline 37
5.3.3 TBI Therapeutics –Phase I Pipeline 38
5.3.4 TBI Therapeutics – Preclinical Phase 38
5.3.5 TBI Therapeutics – Discovery Pipeline 38
5.4 Technology Trends Analytic Framework 39
5.5 TBI Therapeutics – Clinical Pipeline by Mechanism of Action 41
5.6 TBI Therapeutics – Promising Drugs under Clinical Development 42
5.7 Molecule Profiling for Promising Drugs under Clinical development 42
5.7.1 BHR-100 42
5.7.2 NHOO1 43
5.8 Key Takeaway 43
6 TBI Therapeutics: Clinical Trials Mapping 44
6.1 Clinical Trials by Region/ Country 44
6.2 Clinical Trials by Phase 45
6.3 Clinical Trials by Trial Status 46
6.4 Top 10 companies participating in Therapeutics Clinical Trials 47
6.5 Prominent Sponsors 48
7 TBI Therapeutics: Strategic Assessment 50
7.1 Key Events Impacting the Future Market 50
7.2 Implications for Future Market Competition 51
8 TBI Therapeutics: Future Players 52
8.1 Introduction 52
8.2 Company Profiles 52
8.2.1 BHR Pharma, LLC 52
8.2.2 Vasopharm GmbH 53
8.2.3 NeuroHealing Pharmaceuticals Inc. 54
9 TBI Therapeutics: Licensing and Partnership Deals 55
10 TBI Therapeutics: Appendix 56
10.1 Market Definitions 56
10.2 Abbreviations 56
10.3 Research Methodology 57
10.3.1 Coverage 57
10.3.2 Secondary Research 57
10.3.3 Forecasting 58
10.3.4 Primary Research 61
10.3.5 Expert Panel Validation 61
10.4 Contact Us 61
10.5 Disclaimer 61
10.6 Bibliography 62




...